JCL Roundtable: Is inflammation a future target in preventing arteriosclerotic cardiovascular disease

Journal of Clinical Lipidology

Volumn 9, Issue 2, 2015, Pages 119-128

  Brown, W Virgil ^a   Remaley, Alan T ^b   Ridker, Paul M ^c  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Apolipoprotein B; ASCVD; Atherosclerosis; Inflammation; Prevention

Indexed keywords

APOLIPOPROTEIN B; C REACTIVE PROTEIN; HIGH DENSITY LIPOPROTEIN; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; VERY LOW DENSITY LIPOPROTEIN;

ATHEROSCLEROSIS; CLINICAL TRIAL (TOPIC); HUMAN; INFLAMMATION; INNATE IMMUNITY; LIPID STORAGE; LIPOPROTEIN BLOOD LEVEL; MACROPHAGE; MENDELIAN RANDOMIZATION ANALYSIS; PRIORITY JOURNAL; REVIEW; ARTERIOSCLEROSIS; ARTERY; COMPLICATION; GENETICS; LEUKOCYTE; LIPID METABOLISM; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; RISK FACTOR; SIGNAL TRANSDUCTION;

APOLIPOPROTEINS B; ARTERIES; ARTERIOSCLEROSIS; HUMANS; INFLAMMATION; LEUKOCYTES; LIPID METABOLISM; RISK FACTORS; SIGNAL TRANSDUCTION;

EID: 84928824425     PISSN: 19332874     EISSN: 18764789     Source Type: Journal    
DOI: 10.1016/j.jacl.2015.01.007     Document Type: Review

References (7)

1. P. Libby, and G.K. Hansson Inflammation and immunity in diseases of the arterial tree; players and layers Circ Res 116 2015 307 311
2. P. Libby, P.M. Ridker, and G.K. Hansson Progress and challenges in translating the biology of atherosclerosis Nature 473 2011 317 325
3. P.M. Ridker, T. Thuren, A. Zalewski, and P. Libby Interleukin-1β inhibition and the prevention of recurrent cardiovascular events: rationale and design of the Canakinumab Anti-inflammatory Thrombosis Outcomes Study (CANTOS) Am Heart J 162 2011 597 605
4. G.K. Hansson, and L. Jonasson The discovery of cellular immunity in the atherosclerotic plaque Arterioscler Thromb Vasc Biol 29 2009 1714 1717
5. G.S. Abela Cholesterol crystals piercing the arterial plaque and intima trigger local and systemic inflammation J Clin Lipidol 4 2010 156 164
6. D.F. van Wijk, B. Sjouke, and A. Figueroa Nonpharmacological lipoprotein apheresis reduces arterial inflammation in familial hypercholesterolemia J Am Coll Cardiol 64 2014 1418 1426
7. P.M. Ridker, and T.F. Luscher Anti-inflammatory therapies for cardiovascular disease Eur Heart J 35 2014 1782 1791